BioXcel Therapeutics (BTAI) Stock Price & Financial Analysis
BioXcel Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About BioXcel Therapeutics
What is the current stock price for BTAI?
As of the latest trading session, BTAI stock trades at $1.18. The 52-week range is $1.15–$8.08, with a day range of $1.08–$1.22.
What is the P/E ratio for BTAI?
The P/E ratio (Price-to-Earnings) for BTAI is shown in the Key Statistics section. This valuation metric helps compare BioXcel Therapeutics, Inc. to industry peers.
Does BTAI pay dividends?
BioXcel Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for BTAI?
Based on 2 analysts, the consensus for BTAI is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of BTAI?
BioXcel Therapeutics's market capitalization is $16.8M, classifying it as a micro-cap company. BioXcel Therapeutics operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.